A STUDY OF FADROZOLE, A NEW AROMATASE INHIBITOR, IN POSTMENOPAUSAL WOMEN WITH ADVANCED METASTATIC BREAST-CANCER

被引：62

作者：

RAATS, JI ^{[1
]}

FALKSON, G ^{[1
]}

FALKSON, HC ^{[1
]}

机构：

[1] UNIV PRETORIA,DEPT MED ONCOL,POB 667,PRETORIA 0001,SOUTH AFRICA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 01期

关键词：

D O I：

10.1200/JCO.1992.10.1.111

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：111 / 116

页数：6

共 26 条

[1] AROMATASE INHIBITORS AND THEIR POTENTIAL CLINICAL-SIGNIFICANCE [J].

BRODIE, AMH ;

WING, LY ;

GOSS, P ;

DOWSETT, M ;

COOMBES, RC .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (5B) :859-865

[2] AROMATASE INHIBITORS - BASIC AND CLINICAL-STUDIES [J].

BRODIE, AMH ;

COOMBES, RC ;

DOWSETT, M .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 27 (4-6) :899-903

[3] AROMATASE IN BREAST-CANCER AND THE ROLE OF AMINOGLUTETHIMIDE AND OTHER AROMATASE INHIBITORS [J].

BRODIE, AMH ;

SANTEN, RJ .

CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1986, 5 (04) :361-396

[4] ORAL 4-HYDROXYANDROSTENEDIONE, A NEW ENDOCRINE TREATMENT FOR DISSEMINATED BREAST-CANCER [J].

CUNNINGHAM, D ;

POWLES, TJ ;

DOWSETT, M ;

HUTCHISON, G ;

BRODIE, AMH ;

FORD, HT ;

GAZET, JC ;

COOMBES, RC .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) :253-255

[5] POTENCY AND SELECTIVITY OF THE NONSTEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST-CANCER PATIENTS [J].

DOWSETT, M ;

STEIN, RC ;

MEHTA, A ;

COOMBES, RC .

CLINICAL ENDOCRINOLOGY, 1990, 32 (05) :623-634

[6]

DOWSETT M, 1985, LANCET, V1, P175

[7]

FALKSON G, 1983, CANCER CHEMOTH PHARM, V11, P16

[8]

Fisher R.A., 1934, BIOL MONOGRAPHS MANU, V5

[9]

GELBER RD, 1985, MED ONCOL, P406

[10]

HARRIS AL, 1985, BREAST CANCER RES TR, V5, P201

← 1 2 3 →